Literature DB >> 18577386

The effect of corticosteroid treatment on local immune responses, intake and performance in lambs infected with Teladorsagia circumcincta.

A W Greer1, J F Huntley, A Mackellar, R W McAnulty, N P Jay, R S Green, M Stankiewicz, A R Sykes.   

Abstract

The nutritional cost of, and the sequential cellular changes associated with the developing immune response to the abomasal parasite Teladorsagia circumcincta were investigated using corticosteroid-induced immune-suppression. Six-month-old lambs with minimal nematode experience were either infected with 4000 L3 T. circumcincta per day (group IF), similarly infected and concurrently immune-suppressed with methylprednisolone acetate (group ISIF), immune-suppressed only (group IS) or remained as controls (group C). Food intake, faecal egg count (FEC) and antibody titres in plasma were recorded weekly, worm burden at necropsy on day 63 p.i. and body composition by X-ray computed tomography on days -2 and 62 p.i. Furthermore, sequential immunological changes at the site of parasite infestation in the abomasal mucosa were measured from serial biopsy tissue samples taken from additional animals that were fitted with an abomasal cannula and either infected with the same regime as IF animals above (group CnIF) or concurrently infected and immune-suppressed as above (group CnISIF). Corticosteroid treatment resulted in greater FECs (P<0.01) and worm burdens (P<0.01) in both ISIF and CnISIF compared with IF and CnIF sheep, respectively. Infection reduced feed intake by 17% between 14 and 28 days p.i. (P<0.05) and efficiency of energy utilisation by 20% (P=0.07) in IF animals but not in ISIF animals. Mast cells, globule leukocytes and IgA in tissue biopsy samples were elevated in CnIF from 42 days p.i., all of which were abrogated by corticosteroid treatment. The ability to regulate the worm population appeared to be associated with a rise in tissue IgA concentration and numbers of globule leucocytes (GL). The results support the hypothesis that a majority of the production losses that occur during infection of lambs with T. circumcincta in lambs are a consequence of the host immune response. These findings may have implications for regimes that promote the development of a strong host immune reaction to gastrointestinal parasites in lambs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577386     DOI: 10.1016/j.ijpara.2008.05.010

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  5 in total

Review 1.  The immunology and genetics of resistance of sheep to Teladorsagia circumcincta.

Authors:  Virginia M Venturina; Anton G Gossner; John Hopkins
Journal:  Vet Res Commun       Date:  2013-02-22       Impact factor: 2.459

2.  A comparative study of the effects of four treatment regimes on ivermectin efficacy, body weight and pasture contamination in lambs naturally infected with gastrointestinal nematodes in Scotland.

Authors:  Fiona Kenyon; David McBean; Andrew W Greer; Charlotte G S Burgess; Alison A Morrison; David J Bartley; Yvonne Bartley; Leigh Devin; Mintu Nath; Frank Jackson
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-03-06       Impact factor: 4.077

3.  Benzimidazole resistance of sheep nematodes in Norway confirmed through controlled efficacy test.

Authors:  Atle V Meling Domke; Christophe Chartier; Bjørn Gjerde; Snorre Stuen
Journal:  Acta Vet Scand       Date:  2012-08-29       Impact factor: 1.695

Review 4.  Go with the flow-biology and genetics of the lactation cycle.

Authors:  Eva M Strucken; Yan C S M Laurenson; Gudrun A Brockmann
Journal:  Front Genet       Date:  2015-03-26       Impact factor: 4.599

5.  Suppression of ovine lymphocyte activation by Teladorsagia circumcincta larval excretory-secretory products.

Authors:  Tom N McNeilly; Mara Rocchi; Yvonne Bartley; Jeremy K Brown; David Frew; Cassandra Longhi; Louise McLean; Jenni McIntyre; Alasdair J Nisbet; Sean Wattegedera; John F Huntley; Jacqueline B Matthews
Journal:  Vet Res       Date:  2013-08-21       Impact factor: 3.683

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.